Adamcsik Bernadett, Nagy Enikő, Urbán Béla, Szabó Péter, Pekker Péter, Skoda-Földes Rita
Institute of Chemistry, Department of Organic Chemistry, University of Pannonia Egyetem u. 10 Veszprém 8200 Hungary
Institute of Chemistry, Department of Analytical Chemistry, University of Pannonia Egyetem u. 10 Veszprém 8200 Hungary.
RSC Adv. 2020 Jun 23;10(40):23988-23998. doi: 10.1039/d0ra03406a. eCollection 2020 Jun 19.
A new SILP (Supported Ionic Liquid Phase) palladium catalyst was prepared and characterized by C and Si CP MAS NMR, DTG, FTIR and TEM. The presence of the grafted pyridinium cations on the surface of the support was found to result in the formation of highly dispersed Pd nanoparticles with their diameter in the range of 1-2 nm. The catalyst was proved to be active not only in the aminocarbonylation of some model compounds but also in the synthesis of active pharmaceutical ingredients. Catalyst recycling and palladium leaching studies were carried out for the first time in aminocarbonylations leading to CX-546(1-(1,4-benzodioxan-6-ylcarbonyl)piperidine), Moclobemide, Nikethamide and a precursor of Finasteride. The latter reaction proves that not only aryl iodides but also an iodoalkene can be converted into the products with the help of the heterogeneous catalyst. The results show that the conditions should be always fine-tuned in the reactions of different substrates to achieve optimal results. Palladium loss was also observed to depend considerably on the nature of the reaction partners.
制备了一种新型的固载离子液体相(SILP)钯催化剂,并通过碳和硅的交叉极化魔角旋转核磁共振(C和Si CP MAS NMR)、微商热重(DTG)、傅里叶变换红外光谱(FTIR)和透射电子显微镜(TEM)对其进行了表征。结果发现,载体表面接枝的吡啶鎓阳离子的存在导致形成了高度分散的钯纳米颗粒,其直径在1-2纳米范围内。该催化剂不仅在一些模型化合物的氨甲酰化反应中具有活性,而且在活性药物成分的合成中也具有活性。首次对导致CX-546(1-(1,4-苯并二氧六环-6-基羰基)哌啶)、吗氯贝胺、尼可刹米和非那雄胺前体的氨甲酰化反应进行了催化剂循环利用和钯浸出研究。后一个反应证明,借助多相催化剂,不仅芳基碘化物,而且碘代烯烃也可以转化为产物。结果表明,在不同底物的反应中,条件应始终进行微调以获得最佳结果。还观察到钯的损失在很大程度上取决于反应伙伴的性质。